Market Tracker

05/30 4:45pm ET

TG Therapeutics Inc (NASDAQ:TGTX)

7.73
Delayed Data
As of May 27
 +0.51 / +7.06%
Today’s Change
6.95
Today|||52-Week Range
19.05
-35.21%
Year-to-Date
No recent news for TG Therapeutics Inc.

Today’s Trading

Previous close7.22
Today’s open7.85
Day’s range7.41 - 7.86
Volume843,587
Average volume (3 months)389,673
Market cap$420.0M
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+15.85%
Earnings growth (this year)+11.90%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales3,573.69
Price/Book4.11

Competitors

 Today’s
change
Today’s
% change
ARNAArena Pharmaceutical...+0.13+8.02%
OTICOtonomy Inc+0.12+0.84%
ACRSAclaris Therapeutics...+0.30+1.52%
SGNTSagent Pharmaceutica...+0.44+3.69%
Data as of 3:59pm ET, 05/27/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$152.4K
Annual profit (last year)-$62.9M
Net profit margin-41,310.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Michael Sean Weiss
CFO, Secretary, Treasurer &
CAO
Sean A. Power
Corporate headquarters
New York, New York

Forecasts